thinkpool

계열회사 변경 
 
 
  증권거래법 제186조의 규정에 의하여 당사의 주요경영사항에 대해 다음과 같이 신고ㆍ공시 
  합니다. 
 
 
                                  2006년     9월     22일 
 
                              금융감독위원회(금융감독원) 귀중 
 
 
  회   사   명 :                주식회사 나노엔텍 
       (영문명)                 NanoenTek,Inc. 
       (홈페이지)               http://www.future.co.kr 
 
 
  본 점 소 재 지 :              서울시 구로구 구로동 235-2 에이스하이엔드타워12층 
       (전   화)                02-6220-7777 
 
 
  대 표 이 사 :                 장 준 근 
 
 
  담 당 임 원 :                 (직  책)부사장 
                                (성  명)정 용 제              (전  화)02-6220-7704 
 
 
 
  작   성   자 :                (직  책)과장 
                                (성  명)한 명 석              (전  화)02-6220-7715 
 
 
 
  제 출 이 유 :                               유가증권의발행및공시등에관한규정 제69조제1항 
                                              제2호타목에 의한 
                                              계열회사 변경 
+------------------------------------------------------------------------------------------+ 
| ※ 본 건 금융감독위원회(금융감독원)에 제출하는 주요경영사항 신고는 증권거래법 제186조,   | 
| 동법 시행령 제83조 및 유가증권의발행및공시등에관한규정 제69조에 의한 『법정공시사항』    | 
| 으로 그 내용에 허위, 중요사실의 누락이 있을 경우 증권거래법 제206조의11, 제207조의3에    | 
| 의거 과징금 부과, 형사처벌 등 제재를 받을 수 있습니다.                                   | 
+------------------------------------------------------------------------------------------+ 
+---------------------------------------+--------------------------------------------------+ 
| 1. 변경내용                           |                  계열회사 추가                   | 
+-------------------+-------------------+--------------------------------------------------+ 
| 2. 계열회사       |       회사명      | (주)디지탈바이오테크놀러지                       | 
|                   +-------------------+--------------------------------------------------+ 
|    내용           |       대표자      | 장준근                                           | 
|                   +-------------------+-----------+-----------+-----------+--------------+ 
|                   |   주요 재무현황   | 자산총액 (| 2,703,387,| 자본총액 (|  581,661,762 | 
|                   |                   |    원)    |        975|    원)    |              | 
|                   |                   +-----------+-----------+-----------+--------------+ 
|                   |                   | 부채총액 (| 2,121,726,| 자본금 (원| 1,996,000,00 | 
|                   |                   |    원)    |        213|     )     |            0 | 
|                   +-------------------+--------------------------------------------------+ 
|                   |      주요사업     | 1.나노기술개발 및 제조 판매업                    | 
|                   |                   | 2. 나노생명공학, 나노의약 기술개발 및 제조 판매  | 
|                   |                   | 업                                               | 
|                   |                   | 3. 나노전자의료기기 제조 및 판매업               | 
+---------------------------------------+--------------------------------------------------+ 
| 3. 계열그룹명                         | 나노엔텍                                         | 
+---------------------------------------+--------------------------------------------------+ 
| 4. 변경사유                           | 포괄적주식교환으로 완전자회사 편입               | 
+-------------------+-------------------+--------------------------------------------------+ 
| 5. 계열회사수     |     변경전(사)    |                                                0 | 
|                   +-------------------+--------------------------------------------------+ 
|                   |     변경후(사)    |                                                2 | 
+---------------------------------------+--------------------------------------------------+ 
| 6. 변경일자                           |                 2006년 09월 22일                 | 
+---------------------------------------+--------------------------------------------------+ 
| 7. 확인일자                           |                 2006년 09월 22일                 | 
+------------------------------------------------------------------------------------------+ 
8. 기타 투자판단에 참고할 사항 
- 상기 변경일은 주식교환일임.